How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants?

Background The New Medicines Service (NMS) was implemented in the United Kingdom in 2011 and first evaluated in 2014, showing 10% increase on adherence. Objective To assess community pharmacists’ current practice, knowledge and confidence in supporting patients’ adherence as part of the NMS for pati...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical pharmacy 2017-12, Vol.39 (6), p.1273-1281
Main Authors: Hamedi, Nadya, da Costa, Filipa Alves, Horne, Robert, Levitan, Michael, Begley, Amanda, Antoniou, Sotiris
Format: Article
Language:English
Subjects:
Administration, Oral
Antagonists
Anticoagulants
Anticoagulants - administration & dosage
Anticoagulants - therapeutic use
Atrial Fibrillation - drug therapy
Cardiac arrhythmia
Coagulants
Committees
Community Pharmacy Services
Consultation
Cross-Sectional Studies
Female
Fibrillation
Health Knowledge, Attitudes, Practice
Humans
Internal Medicine
Male
Medication Adherence
Medicine
Medicine & Public Health
Patient compliance
Pharmaceuticals
Pharmacists - psychology
Pharmacy
Research Article
Skills
Stroke
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The New Medicines Service (NMS) was implemented in the United Kingdom in 2011 and first evaluated in 2014, showing 10% increase on adherence. Objective To assess community pharmacists’ current practice, knowledge and confidence in supporting patients’ adherence as part of the NMS for patients on Oral Anti-Coagulants (OACs) for stroke prevention in Atrial Fibrillation. Setting Community pharmacists in London. Method An online cross-sectional survey was sent to pharmacists from their Local Pharmaceutical Committees and advertised by the Royal Pharmaceutical Society. Analysis was undertaken in SPSs v23 considering a confidence level of 95%. Main outcome measures pharmacists reported confidence of providing the NMS on OACs; training needs and skills for supporting adherence. Results A total of 257 valid responses were analysed (6.8% response rate; {Cronbach’s α = 0.676–0.892}). Data indicates that over a 2-month period, 25% of pharmacists had completed ≥6 NMS consultations for all OACs, of which 11% for new oral anticoagulants (NOACs). The key priorities in counselling items during the NMS consultation were to discuss actions to take when bleeding occurs, followed by supporting adherence. Pharmacists were more confident in their knowledge, skills and access to resources for Vitamin-K Antagonists (VKAs) than for NOACs ( p  
ISSN:2210-7703
2210-7711
DOI:10.1007/s11096-017-0529-0